Translate
TORONTO, Oct. 31, 2011 /CNW/ - Microbix Biosystems Inc. ("Microbix" or the "Company")(TSX:MBX) is pleased to announce that it has undertaken an overnight marketed offering of Units. The Units are comprised of common shares of the Company and common share purchase warrants. The offering is to be effected in provinces of Ontario, Alberta and British Columbia by way of a prospectus supplement to be Microbix' base shelf prospectus dated October 7, 2011. The number of Units to be distributed, the price of each Unit and the exercise price of each whole common share purchase warrant will be determined in the context of the market, with the final terms to be determined at the time of pricing. The Units are offered through Euro Pacific Canada Inc. as Agent.
Closing of the offering is subject to certain conditions, including but not limited to, receipt of all necessary securities regulatory approvals, including the approval of the Toronto Stock Exchange.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities of the Corporation in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities to be offered have not been and will not be registered under the Unites States Securities Act of 1933, as amended, or any state securities laws, and may not be offered or sold within the United States absent registration or an applicable exemption from the registration requirements of the Unites States Securities Act of 1933, as amended, and applicable state securities laws.